The frequency of limb girdle muscular dystrophy 2A in northeastern Italy

被引:65
作者
Fanin, M
Nascimbeni, AC
Fulizio, L
Angelini, C
机构
[1] Venetian Inst Mol Med, I-35129 Padua, Italy
[2] Univ Padua, Dept Neurosci, Padua, Italy
关键词
limb-girdle muscular dystrophy; LGMD2A; calpain-3; genetic epidemiology;
D O I
10.1016/j.nmd.2004.11.003
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Limb-girdle muscular dystrophy 2A (LGMD2A) is considered to be the most frequent LGMD. Our study surveyed an area in northeastern Italy where an almost complete ascertainment was possible. To identify LGMD2A patients we used a new diagnostic approach, including several molecular and biochemical methods. In 84 screened patients from northeastern Italy, we identified 39 LGMD2A patients, the prevalence of LGMD2A being 9.47 per million. In the Venezia district it appears higher than in other districts of the Veneto region, and in the Friuli region it is three times higher than in Veneto, due to the recurrence of single mutation. Haplotype analysis suggested a founder effect. The population from Venezia and Friuli has a higher risk of being heterozygote for these two mutant alleles than people from the rest of northeastern Italy. Our results indicate that LGMD2A is one of the most frequent autosomal recessive disorders, thus finding its molecular characterization becoming increasingly important. (c) 2004 Elsevier B.V. All rights reserved.
引用
收藏
页码:218 / 224
页数:7
相关论文
共 26 条
[1]   Characterization of monoclonal antibodies to calpain 3 and protein expression in muscle from patients with limb-girdle muscular dystrophy type 2A [J].
Anderson, LVB ;
Davison, K ;
Moss, JA ;
Richard, I ;
Fardeau, M ;
Tomé, FMS ;
Hübner, C ;
Lasa, A ;
Colomer, J ;
Beckmann, JS .
AMERICAN JOURNAL OF PATHOLOGY, 1998, 153 (04) :1169-1179
[2]  
BECKMANN JS, 1991, CR ACAD SCI III-VIE, V312, P141
[3]  
Bushby K M D, 2003, Neuromuscul Disord, V13, P80, DOI 10.1016/S0960-8966(02)00183-9
[4]   Prevalence of the 550delA mutation in calpainopathy (LGMD 2A) in Croatia [J].
Canki-Klain, N ;
Milic, A ;
Kovac, B ;
Trlaja, A ;
Grgicevic, D ;
Zurak, N ;
Fardeau, M ;
Leturcq, F ;
Kaplan, JC ;
Urtizberea, JA ;
Politano, L ;
Piluso, G ;
Feingold, J .
AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 2004, 125A (02) :152-156
[5]   Calpain III mutation analysis of a heterogeneous limb-girdle muscular dystrophy population [J].
Chou, FL ;
Angelini, C ;
Daentl, D ;
Garcia, C ;
Greco, C ;
Hausmanowa-Petrusewicz, I ;
Fidzianska, A ;
Wessel, H ;
Hoffman, EP .
NEUROLOGY, 1999, 52 (05) :1015-1020
[6]   GEOGRAPHIC DISTRIBUTION OF HEREDITARY MYOPATHIES IN NORTHEAST ITALY [J].
DANIELI, GA ;
VECCHI, C ;
ANGELINI, C .
SOCIAL BIOLOGY, 1974, 21 (03) :235-241
[7]   Clinical variability in calpainopathy: What makes the difference? [J].
de Paula, F ;
Vainzof, M ;
Passos-Bueno, MR ;
Pavanello, RDM ;
Matioli, SR ;
Anderson, LVB ;
Nigro, V ;
Zatz, M .
EUROPEAN JOURNAL OF HUMAN GENETICS, 2002, 10 (12) :825-832
[8]   A biochemical, genetic, and clinical survey of autosomal recessive limb girdle muscular dystrophies in Turkey [J].
Dincer, P ;
Leturcq, F ;
Richard, I ;
Piccolo, F ;
Yalnizoglu, D ;
deToma, C ;
Akcoren, Z ;
Broux, O ;
Deburgrave, N ;
Brenguier, L ;
Roudaut, C ;
Urtizberea, JA ;
Jung, D ;
Tan, E ;
Jeanpierre, M ;
Campbell, KP ;
Kaplan, JC ;
Beckmann, JS ;
Topaloglu, H .
ANNALS OF NEUROLOGY, 1997, 42 (02) :222-229
[9]   Molecular diagnosis in LGMD2A: Mutation analysis or protein testing? [J].
Fanin, M ;
Fulizio, L ;
Nascimbeni, AC ;
Spinazzi, M ;
Piluso, G ;
Ventriglia, VM ;
Ruzza, G ;
Siciliano, G ;
Trevisan, CR ;
Politano, L ;
Nigro, V ;
Angelini, C .
HUMAN MUTATION, 2004, 24 (01) :52-62
[10]   Loss of calpain-3 autocatalytic activity in LGMD2A patients with normal protein expression [J].
Fanin, M ;
Nascimbeni, AC ;
Fulizio, L ;
Trevisan, CP ;
Meznaric-Petrusa, M ;
Angelini, C .
AMERICAN JOURNAL OF PATHOLOGY, 2003, 163 (05) :1929-1936